THIS EXHIBIT HAS BEEN REDACTED AND IS THE SUBJECT OF A CONFIDENTIAL TREATMENT REQUEST. REDACTED MATERIAL IS MARKED WITH [***] AND HAS BEEN FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. Dated: 5 June 2009 OXFORD IMMUNOTEC LIMITED and...Distributor Agreement • October 15th, 2013 • Oxford Immunotec Global PLC • In vitro & in vivo diagnostic substances
THIS EXHIBIT HAS BEEN REDACTED AND IS THE SUBJECT OF A CONFIDENTIAL TREATMENT REQUEST. REDACTED MATERIAL IS MARKED WITH [***] AND HAS BEEN FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. Dated: 5 June 2009 OXFORD IMMUNOTEC LIMITED and...Distributor Agreement • September 10th, 2013 • Oxford Immunotec Global PLC • In vitro & in vivo diagnostic substances